Genovis AB — Investor Relations & Filings

Genovis AB develops and sells innovative enzyme technologies for the biopharmaceutical and research industries. The company's portfolio of proprietary "SmartEnzymes" provides rapid and easy-to-use tools for the analysis, modification, and production of complex biological drugs, particularly therapeutic antibodies and antibody-drug conjugates (ADCs). These products are engineered to facilitate and accelerate workflows throughout the drug development pipeline, from early-stage research and characterization to quality control and large-scale bioprocess manufacturing. The technology enables precise protein analysis and is supplied at quantities suitable for the production of clinical materials.